NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/29/2024
Back to search
Official data from USPTO
GENFIT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GENFIT
ST13
US500000076365742Class
5, 42, 44
Filing
76365742
Registration
2865973
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
05/23/2025
Trademark type
Word
Nice classes
5, 42, 44
Filing date
01/31/2002
Registration date
07/27/2004
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/29/2024
Last transaction
05/23/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
1
Owner type
03
Owner location
Loos, FR
Examiner
MCMORROW, RONALD
Law office
L50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
GENFIT
Representatives
Ronald M. Kachmarik Cooper Legal Group LLC
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for use in the treatment of cardiovascular diseasesdermatological diseasesmetabolic disordersinflammatory disordersskin and mucosal disordersdisorders in the central nervous systeminfectionscancers and oncological disordersimmunodeficiency and immunologic disordersasthmaallergieslipidic disordersobesity and diabetes; veterinary pharmaceutical preparations for use in the treatment of cardiovascular diseasesdermatological diseasesmetabolic disordersinflammatory disordersskin and mucosal disordersdisorders in the central nervous systemcancersoncological disordersimmunodeficiency and immunologic disordersasthmaallergieslipidic disordersobesity and diabetes; sanitary preparations for diagnosis and for acute and chronic careantibioticantibacterialantiviral and antifungal agents for elimination or reduction of germsbacteriaviruses and fungi; chemical preparations for medicalpharmaceutical or veterinary diagnostic use; enzymatic preparations for medicalpharmaceutical or veterinary use; biological preparationsantibodies and fragments of antibodies for laboratoriesdiagnosticsanalytics for human and veterinary medical diagnostic use; pharmaceutical preparations for the treatment of skin conditionsmedicated skin care preparation for pharmaceutical use; medicated sunburn preventing productscreamsoilslotionsgelsfor pharmaceutical use; slimming medical preparations; cultures of microorganisms for medicalpharmaceutical and veterinary use; media for bacteriological cultures; nutrients for use in medicalpharmaceutical and veterinary research; cell preparations for medicalpharmaceutical or veterinary usein particular for gene therapy and cell therapy; kits consisting primarily of culture mediaculture boxesculture additivesdiagnostic reagents for the preparation of cells or for the selection of biologically active compounds for medicalpharmaceutical or veterinary laboratory testingfor medical or veterinary diagnostic use; diagnostic and biological preparations and cultures of microorganisms and cells for clinical or medical laboratory use; reagents for medicalveterinary and diagnostic usediagnosis productsreagents for medical or veterinary use; chemical and biological reagents for clinical or medical laboratory use; diagnostic preparations for clinical or medical laboratory use; diagnosis reagents for medicalveterinary use and in vitro use in biochemistryclinical chemistry and microbiology; dietetic substancesdietary supplements and food supplements for medical use; dietetic foodstuffs adapted for medical use
Class 42
Pharmaceutical research and development of new drug products for others; scientificbiological and medical research in the fields of pharmacologyanalytical chemistrybiochemistryimmunologygeneticmedicinal chemistrydrug development of new drug products for others; scientificbiological and medical research in the field of pharmacologyanalytical chemistrybiological and medical research in the field of pharmacologyanalytical chemistrybiochemistryimmunologygeneticmedicinal chemistrydrug developmentbiotechnologymicrobiology and molecular biologychemicalbiochemical and biotechnological analysis; basic and applied scientific research; technical researchnamely screening and selection of molecules; validation of biological targets; development and validation of biological testscell testsgenetic testsidentifyingcharacterizingvalidatingdevelopment biologically active molecules through the se of functional genomics; analysis of biological substances in biological fluids; technical consultation in the field of pharmaceuticals; legal services in the field of scientific researchmedical sciences and intellectual property rights; patent agency and licensing; computer programming in the field of scientific researchmedical sciences and intellectual property rights; patent agency and licensing; computer programming in the field of scientific research and for the pharmaceutical industry; surveying and engineering; chemical analysis in the field of pharmacology; technical consultation in the field of pharmacology; consultationnot connected with the conduct of businessin the fields of scientific research and therapy; research and development of new pharmaceutical products for third parties; providing an online electronic computer database in the field of scientific information
Class 44
Providing an online electronic computer database in the field of medical and pharmaceutical information
Publications
History of USPTO decisions and trademark events.
36 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
03/29/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/29/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/29/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
11/06/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/27/2023
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/16/2014
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/16/2014
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/16/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/13/2014
E89R
TEAS SECTION 8 & 9 RECEIVED
07/25/2014
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/13/2010
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/11/2010
E815
TEAS SECTION 8 & 15 RECEIVED
07/22/2010
CORV
REVIEW OF CORRESPONDENCE COMPLETE
02/20/2009
PAPER RECEIVED
02/02/2009
R.PR
REGISTERED-PRINCIPAL REGISTER
07/27/2004
PAPER RECEIVED
05/10/2004
PUBO
PUBLISHED FOR OPPOSITION
05/04/2004
NPUB
NOTICE OF PUBLICATION
04/14/2004
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/02/2003
PAPER RECEIVED
10/20/2003
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/16/2003
CNRT
NON-FINAL ACTION MAILED
08/27/2003
CFIT
CASE FILE IN TICRS
07/16/2003
1.BD
Sec. 1(B) CLAIM DELETED
07/09/2003
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/09/2003
PAPER RECEIVED
07/09/2003
CNSL
LETTER OF SUSPENSION MAILED
01/10/2003
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/13/2002
PAPER RECEIVED
11/13/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/08/2002
DOCK
ASSIGNED TO EXAMINER
10/17/2002
CNRT
NON-FINAL ACTION MAILED
05/08/2002
PAPER RECEIVED
04/29/2002
DOCK
ASSIGNED TO EXAMINER
04/19/2002
Continuous trademark protection
Get notified about every new filing that threatens GENFIT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.